MAPK14 and colorectal carcinoma: Down-regulation of CB1 receptor observed in metastatic CRC patients was linked to a decrease of downstream signaling such as the p38 mitogen activated protein kinase (MAPK) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) pathway.